Preview Mode Links will not work in preview mode

This Week in Cardiology

Mar 25, 2022

AF ablation vs rate control in HF, TAVI vs SAVR, atherosclerosis, and surrogate endpoints in observational studies are the topics John Mandrola, MD, discusses in this week’s podcast.

This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit:

I – AF ablation vs Rate Control

RAFT-AF, Despite Itself, Hints at Advantage for Ablation Rhythm Control in Heart Failure With AF

• Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients with Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trial

• Catheter Ablation for Atrial Fibrillation with Heart Failure

• Lenient versus Strict Rate Control in Patients with Atrial Fibrillation


Surgery Groups Push Back on VARC-3 Valve Trial Definitions

• Joint Surgical Associations (EACTS, LACES, ASCVTS, AATS, and STS) Position Statement Regarding the VARC-3 Definitions for Aortic Valve Clinical Research

III – Atherosclerosis

Medical Management Best for Atherosclerotic Stroke: New AAN Guidance

• Stroke Prevention in Symptomatic Large Artery Intracranial Atherosclerosis Practice Advisory

IV – ECHO parameters with Rhythm Control

Global Gains in Heart Function From Early AF Rhythm Control

• Restoring Sinus Rhythm Reverses Cardiac Remodeling and Reduces Valvular Regurgitation in Patients With Atrial Fibrillation

• Effects of Atrial Fibrillation and Sinus Rhythm on Cardiac Remodeling and Valvular Regurgitation

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

Questions or feedback, please contact